Detalhe da pesquisa
1.
Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Front Neuroendocrinol
; 62: 100914, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845041
2.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
BMC Cancer
; 21(1): 64, 2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446148
3.
Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing.
Neural Regen Res
; 17(8): 1652-1658, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017411
4.
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group.
J Geriatr Oncol
; 12(3): 410-415, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357975
5.
Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report.
Case Rep Oncol
; 13(1): 69-75, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32110222
6.
Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report.
Front Oncol
; 9: 819, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31552167